Behavioral interventions in multiple sclerosis: a biopsychosocial perspective

Area of Science:

• Neurology
• Neuroimmunology
• Behavioral Medicine

Background:

• Multiple sclerosis (MS) diagnosis involves managing uncertainty and prevalent neuropsychiatric symptoms, particularly depression.
• While immunomodulatory treatments for MS have advanced, their long-term functional benefits remain debated, with limited reported improvements in patient function.
• Current MS therapies effectively target inflammatory lesions and relapse rates but rarely enhance overall function.

Purpose of the Study:

• To evaluate the impact of behavioral interventions on symptoms and disease activity in multiple sclerosis.
• To explore the potential of behavioral approaches to complement or modify the course of MS.

Main Methods:

• Review of recent evidence on behavioral interventions for multiple sclerosis.
• Analysis of studies examining effects on fatigue, depression, motor function, and inflammatory markers.

Main Results:

• Behavioral interventions have demonstrated significant improvements in fatigue, depression, and motor function in MS patients.
• Emerging evidence suggests that group education and face-to-face behavioral interventions may reduce inflammatory disease activity, including relapse rates and MRI-detected lesions.
• These interventions show promise in ameliorating symptoms and potentially altering the disease process itself.

Conclusions:

• Behavioral interventions offer a valuable therapeutic strategy for multiple sclerosis, addressing both symptomatic relief and potential disease modification.
• Beyond symptom management, behavioral interventions may influence the underlying inflammatory processes in multiple sclerosis.
• The findings support the integration of behavioral interventions into comprehensive multiple sclerosis care plans.